Clinical Efficacy of Subcutaneous Allergen Immunotherapy in Patients with Atopic Dermatitis.

about

Clinical Diversity of Atopic Dermatitis: A Review of 5,000 Patients at a Single Institute.

P2860

Q37606278-A2338DF7-8226-4D57-8DF3-6C31DFEB0B29

P2860

Clinical Efficacy of Subcutaneous Allergen Immunotherapy in Patients with Atopic Dermatitis.

Item

http://www.wikidata.org/entity/Q37231881

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Clinical Efficacy of Subcutane ...... tients with Atopic Dermatitis.

@en

Clinical Efficacy of Subcutane ...... tients with Atopic Dermatitis.

@nl

type

Item

label

Clinical Efficacy of Subcutane ...... tients with Atopic Dermatitis.

@en

Clinical Efficacy of Subcutane ...... tients with Atopic Dermatitis.

@nl

prefLabel

Clinical Efficacy of Subcutane ...... tients with Atopic Dermatitis.

@en

Clinical Efficacy of Subcutane ...... tients with Atopic Dermatitis.

@nl

P1476

Clinical Efficacy of Subcutane ...... tients with Atopic Dermatitis.

@en

P2093

Areum Ahn

http://www.w3.org/2001/XMLSchema#string

Byul Kwon

http://www.w3.org/2001/XMLSchema#string

Dong Ho Nahm

http://www.w3.org/2001/XMLSchema#string

Myoung Eun Kim

http://www.w3.org/2001/XMLSchema#string

Su Mi Cho

http://www.w3.org/2001/XMLSchema#string

P2860

Personalized Immunomodulatory Therapy for Atopic Dermatitis: An Allergist's View

Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis

Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper.

Safety of accelerated schedules of subcutaneous allergen immunotherapy with house dust mite extract in patients with atopic dermatitis.

Specific immunotherapy in atopic dermatitis.

Treatment of severe atopic dermatitis with a combination of subcutaneous allergen immunotherapy and cyclosporin.

Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report.

Retrospective Analysis on the Effects of House Dust Mite Specific Immunotherapy for More Than 3 Years in Atopic Dermatitis.

Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce.

Autologous Immunoglobulin Therapy in Patients With Severe Recalcitrant Atopic Dermatitis: Long-Term Changes of Clinical Severity and Laboratory Parameters

P304

1420-1426

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3349/YMJ.2016.57.6.1420

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27593870

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

5011274

http://www.w3.org/2001/XMLSchema#string

Clinical Efficacy of Subcutaneous Allergen Immunotherapy in Patients with Atopic Dermatitis.

about

P2860

P2860

Clinical Efficacy of Subcutaneous Allergen Immunotherapy in Patients with Atopic Dermatitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932